Stimson W H, McAdam A, Lang G, Dodd J
Int J Cancer. 1985 Feb 15;35(2):185-7. doi: 10.1002/ijc.2910350208.
Pregnancy-associated beta 1-macroglobulin (beta 1-PAM) is a serum protein which can be detected at elevated levels in the blood of many ovarian cancer patients. The presence of the antigen was investigated on the surface of 4 human ovarian cancer lines and 32 other human and rodent cell types and lines by means of immunofluorescent staining and anti-beta 1-PAM-enzyme conjugate. The antigen was detected only on the ovarian lines but no secretion of beta 1-PAM into the culture supernatants was observed. The ovarian cancer cells appeared to display the beta 1-PAM constantly during culture, and enzymic treatment of the cells indicated that detection of the cell-bound antigen with antiserum could be, at least partially, eliminated with proteases but not glycosidases or neuraminidase. The results serve to confirm the association of beta 1-PAM with ovarian cancer.
妊娠相关β1-巨球蛋白(β1-PAM)是一种血清蛋白,在许多卵巢癌患者的血液中可检测到其水平升高。通过免疫荧光染色和抗β1-PAM酶偶联物,研究了4种人卵巢癌细胞系以及32种其他人和啮齿动物细胞类型及细胞系表面该抗原的存在情况。仅在卵巢癌细胞系上检测到了该抗原,但未观察到β1-PAM分泌到培养上清液中。在培养过程中,卵巢癌细胞似乎持续表达β1-PAM,对细胞进行酶处理表明,用抗血清检测细胞结合抗原时,蛋白酶可至少部分消除这种检测,而糖苷酶或神经氨酸酶则不能。这些结果有助于证实β1-PAM与卵巢癌的关联。